Literature DB >> 27959635

The Varied Roles of Notch in Cancer.

Jon C Aster1, Warren S Pear2, Stephen C Blacklow3.   

Abstract

Notch receptors influence cellular behavior by participating in a seemingly simple signaling pathway, but outcomes produced by Notch signaling are remarkably varied depending on signal dose and cell context. Here, after briefly reviewing new insights into physiologic mechanisms of Notch signaling in healthy tissues and defects in Notch signaling that contribute to congenital disorders and viral infection, we discuss the varied roles of Notch in cancer, focusing on cell autonomous activities that may be either oncogenic or tumor suppressive.

Entities:  

Keywords:  Notch; cancer hallmarks; cellular transformation; oncogene; tumor suppressor

Mesh:

Substances:

Year:  2016        PMID: 27959635      PMCID: PMC5933931          DOI: 10.1146/annurev-pathol-052016-100127

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  218 in total

1.  Mutations in the human Jagged1 gene are responsible for Alagille syndrome.

Authors:  T Oda; A G Elkahloun; B L Pike; K Okajima; I D Krantz; A Genin; D A Piccoli; P S Meltzer; N B Spinner; F S Collins; S C Chandrasekharappa
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

2.  Structural and mechanistic insights into cooperative assembly of dimeric Notch transcription complexes.

Authors:  Kelly L Arnett; Matthew Hass; Debbie G McArthur; Ma Xenia G Ilagan; Jon C Aster; Raphael Kopan; Stephen C Blacklow
Journal:  Nat Struct Mol Biol       Date:  2010-10-24       Impact factor: 15.369

3.  Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.

Authors:  Alexander Stoeck; Serguei Lejnine; Andrew Truong; Li Pan; Hongfang Wang; Chongzhi Zang; Jing Yuan; Chris Ware; John MacLean; Philip W Garrett-Engele; Michael Kluk; Jason Laskey; Brian B Haines; Christopher Moskaluk; Leigh Zawel; Stephen Fawell; Gary Gilliland; Theresa Zhang; Brandon E Kremer; Birgit Knoechel; Bradley E Bernstein; Warren S Pear; X Shirley Liu; Jon C Aster; Sriram Sathyanarayanan
Journal:  Cancer Discov       Date:  2014-08-07       Impact factor: 39.397

4.  Intrinsic selectivity of Notch 1 for Delta-like 4 over Delta-like 1.

Authors:  Marie Blanke Andrawes; Xiang Xu; Hong Liu; Scott B Ficarro; Jarrod A Marto; Jon C Aster; Stephen C Blacklow
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

5.  Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.

Authors:  Daniel L Abravanel; George K Belka; Tien-chi Pan; Dhruv K Pant; Meredith A Collins; Christopher J Sterner; Lewis A Chodosh
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

Review 6.  MYC-induced cancer cell energy metabolism and therapeutic opportunities.

Authors:  Chi V Dang; Anne Le; Ping Gao
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

7.  Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover.

Authors:  Christy J Fryer; J Brandon White; Katherine A Jones
Journal:  Mol Cell       Date:  2004-11-19       Impact factor: 17.970

8.  Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling.

Authors:  N Brimer; C Lyons; A E Wallberg; S B Vande Pol
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

9.  The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands.

Authors:  Ena Ladi; James T Nichols; Weihong Ge; Alison Miyamoto; Christine Yao; Liang-Tung Yang; Jim Boulter; Yi E Sun; Chris Kintner; Gerry Weinmaster
Journal:  J Cell Biol       Date:  2005-09-06       Impact factor: 10.539

10.  Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin.

Authors:  Kevin G Leong; Kyle Niessen; Iva Kulic; Afshin Raouf; Connie Eaves; Ingrid Pollet; Aly Karsan
Journal:  J Exp Med       Date:  2007-11-05       Impact factor: 14.307

View more
  215 in total

1.  WW domain-mediated regulation and activation of E3 ubiquitin ligase Suppressor of Deltex.

Authors:  Weiyi Yao; Zelin Shan; Aihong Gu; Minjie Fu; Zhifeng Shi; Wenyu Wen
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

2.  Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC.

Authors:  Sara L Sinicropi-Yao; Joseph M Amann; David Lopez Y Lopez; Ferdinando Cerciello; Kevin R Coombes; David P Carbone
Journal:  J Thorac Oncol       Date:  2018-11-05       Impact factor: 15.609

3.  Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques.

Authors:  Jelena Petrovic; Yeqiao Zhou; Maria Fasolino; Naomi Goldman; Gregory W Schwartz; Maxwell R Mumbach; Son C Nguyen; Kelly S Rome; Yogev Sela; Zachary Zapataro; Stephen C Blacklow; Michael J Kruhlak; Junwei Shi; Jon C Aster; Eric F Joyce; Shawn C Little; Golnaz Vahedi; Warren S Pear; Robert B Faryabi
Journal:  Mol Cell       Date:  2019-02-07       Impact factor: 17.970

4.  Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms.

Authors:  Chiara Liverani; Alberto Bongiovanni; Laura Mercatali; Federica Pieri; Chiara Spadazzi; Giacomo Miserocchi; Giandomenico Di Menna; Flavia Foca; Sara Ravaioli; Alessandro De Vita; Claudia Cocchi; Giulio Rossi; Federica Recine; Toni Ibrahim
Journal:  Endocr Pathol       Date:  2021-01-06       Impact factor: 3.943

5.  Dual-Specificity Phosphatase 15 (DUSP15) Modulates Notch Signaling by Enhancing the Stability of Notch Protein.

Authors:  Noopur Bhore; Bo-Jeng Wang; Po-Fan Wu; Yen-Lurk Lee; Yun-Wen Chen; Wen-Ming Hsu; Hsinyu Lee; Yi-Shuian Huang; Ding-I Yang; Yung-Feng Liao
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

6.  Extension of the Notch intracellular domain ankyrin repeat stack by NRARP promotes feedback inhibition of Notch signaling.

Authors:  Sanchez M Jarrett; Tom C M Seegar; Mark Andrews; Guillaume Adelmant; Jarrod A Marto; Jon C Aster; Stephen C Blacklow
Journal:  Sci Signal       Date:  2019-11-05       Impact factor: 8.192

7.  NOTCH SIGNALING IN CONTEXT: BASIC AND TRANSLATIONAL IMPLICATIONS.

Authors:  Jon C Aster
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

8.  Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.

Authors:  Allen S Ho; Angelica Ochoa; Gowtham Jayakumaran; Ahmet Zehir; Cristina Valero Mayor; Justin Tepe; Vladimir Makarov; Martin G Dalin; Jie He; Mark Bailey; Meagan Montesion; Jeffrey S Ross; Vincent A Miller; Lindsay Chan; Ian Ganly; Snjezana Dogan; Nora Katabi; Petros Tsipouras; Patrick Ha; Nishant Agrawal; David B Solit; P Andrew Futreal; Adel K El Naggar; Jorge S Reis-Filho; Britta Weigelt; Alan L Ho; Nikolaus Schultz; Timothy A Chan; Luc Gt Morris
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

9.  Discovery of a ZIP7 inhibitor from a Notch pathway screen.

Authors:  Erin Nolin; Sara Gans; Luis Llamas; Somnath Bandyopadhyay; Scott M Brittain; Paula Bernasconi-Elias; Kyle P Carter; Joseph J Loureiro; Jason R Thomas; Markus Schirle; Yi Yang; Ning Guo; Guglielmo Roma; Sven Schuierer; Martin Beibel; Alicia Lindeman; Frederic Sigoillot; Amy Chen; Kevin X Xie; Samuel Ho; John Reece-Hoyes; Wilhelm A Weihofen; Kayla Tyskiewicz; Dominic Hoepfner; Richard I McDonald; Nicolette Guthrie; Abhishek Dogra; Haibing Guo; Jian Shao; Jian Ding; Stephen M Canham; Geoff Boynton; Elizabeth L George; Zhao B Kang; Christophe Antczak; Jeffery A Porter; Owen Wallace; John A Tallarico; Amy E Palmer; Jeremy L Jenkins; Rishi K Jain; Simon M Bushell; Christy J Fryer
Journal:  Nat Chem Biol       Date:  2019-01-14       Impact factor: 15.040

10.  Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.

Authors:  Orlandric Miree; Sanjeev Kumar Srivastava; Santanu Dasgupta; Seema Singh; Rodney Rocconi; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.